This company seems to have been delisted
Reason: Acquired by Assertio Holdings
Last recorded trade on: October 3, 2023
Source: https://investor.sppirx.com/news-releases/news-release-details/assertio-holdings-inc-acquire-spectrum-pharmaceuticals-inc-all
Reason: Acquired by Assertio Holdings
Last recorded trade on: October 3, 2023
Source: https://investor.sppirx.com/news-releases/news-release-details/assertio-holdings-inc-acquire-spectrum-pharmaceuticals-inc-all
Spectrum Pharmaceuticals
SPPI
S$1.31
Share price
0.00%
Change (1 day)
10.48%
Change (1 year)
Categories
Spectrum Pharmaceuticals (SPPI) - Total liabilities
Total liabilities on the balance sheet as of March 2023 : S$0.10 Billion
According to Spectrum Pharmaceuticals 's latest financial reports the company's total liabilities are S$0.10 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Spectrum Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | S$0.10 B | 16.91% |
| 2021-12-31 | S$86.51 M | 4.54% |
| 2020-12-31 | S$82.75 M | -15.96% |
| 2019-12-31 | S$98.47 M | -33.03% |
| 2018-12-31 | S$0.14 B | -19.23% |
| 2017-12-31 | S$0.18 B | -34.74% |
| 2016-12-31 | S$0.27 B | -5.35% |
| 2015-12-31 | S$0.29 B | -5.27% |
| 2014-12-31 | S$0.31 B | 12.89% |
| 2013-12-31 | S$0.27 B | 1.79% |
| 2012-12-31 | S$0.27 B | 125.14% |
| 2011-12-31 | S$0.12 B | 4.73% |
| 2010-12-31 | S$0.11 B | 26.22% |
| 2009-12-31 | S$90.98 M | -10.21% |
| 2008-12-31 | S$0.10 B | 701% |
| 2007-12-31 | S$12.65 M | 13.51% |
| 2006-12-31 | S$11.14 M | 64.5% |
| 2005-12-31 | S$6.77 M | 46.02% |
| 2004-12-31 | S$4.63 M | -12.14% |
| 2003-12-31 | S$5.28 M | 9.44% |
| 2002-12-31 | S$4.82 M | -56.83% |
| 2001-12-31 | S$11.17 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Teva Pharmaceutical Industries TEVA | S$40.95 B | 39,650.22% | 🇮🇱 Israel |
 Seagen
SGEN | S$1.38 B | 1,240.23% | 🇺🇸 USA |
 Curis CRIS | S$58.51 M | -43.20% | 🇺🇸 USA |
 Biogen BIIB | S$14.08 B | 13,569.35% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | S$95.52 B | 92,615.47% | 🇺🇸 USA |
 Abbott Laboratories ABT | S$41.25 B | 39,944.52% | 🇺🇸 USA |
 Novartis NVS | S$78.33 B | 75,934.38% | 🇨🇭 Switzerland |
 Johnson & Johnson JNJ | S$147.22 B | 142,798.48% | 🇺🇸 USA |
 Pfizer PFE | S$149.55 B | 145,060.13% | 🇺🇸 USA |
 GlaxoSmithKline GSK | S$77.45 B | 75,075.10% | 🇬🇧 UK |